Insilico Medicine ('Insilico', 03696.HK), a clinical-stage biotechnology company driven by generative artificial intelligence ...
The FDA has removed R/R PCNSL from a Limitations of Use section on the CAR-T product’s label based on positive findings from ...
Despite new methodologies and flexible regulatory pathways, CNS biopharmaceuticals still face significant safety assessment ...
Multiple sclerosis (MS) is a chronic disease of the central nervous system. MS disrupts the flow of information between the ...
News Medical on MSN
FDA label update expands CAR T access for primary CNS lymphoma
Dana-Farber Cancer Institute-led research helped drive an FDA label update for axicabtagene ciloleucel (Yescarta) that ...
Updated FDA labeling for Yescarta now includes patients with relapsed or refractory primary CNS lymphoma, expanding treatment options for this group.
A group led by the Department of Neurosurgery at the Brain Research Institute, Niigata University, has successfully diagnosed ...
The U.S. Food and Drug Administration (FDA) has approved an update to the prescribing information for Yescarta (axicabtagene ciloleucel), removing previous limitations of use for adults with relapsed ...
Each part of the nervous system uses internal checks and balances to regulate its activity, responding to various factors like mood, health status, and the external environment.¹ These regulatory ...
Sign up for CNN’s Wonder Theory science newsletter. Explore the universe with news on fascinating discoveries, scientific advancements and more. Caribbean box ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results